v3.25.4
Financial Instruments
12 Months Ended
Dec. 31, 2025
Disclosure of detailed information about financial instruments [abstract]  
Financial Instruments
21.
Financial Instruments

Set out below are the carrying amounts and fair values of the Group’s financial instruments that are carried in the consolidated financial statements as of December 31, 2025 and 2024, respectively.

 

 

Carrying amount per measurement category

 

 

 

 

 

 

 

 

Financial assets as of December 31,
2025

 

 

Financial liabilities as of December 31,
2025

 

 

 

 

 

 

 

(Euros in thousands)

 

At fair value
through profit
and loss

 

 

At amortized
cost

 

 

At fair value
through profit
and loss

 

 

At amortized
cost

 

 

IFRS 7 not
applicable and
IFRS 16

 

 

December 31, 2025

 

Current/non-current assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

 

 

 

345,918

 

 

 

 

 

 

 

 

 

 

 

 

345,918

 

Short-term deposits*

 

 

 

 

 

123,419

 

 

 

 

 

 

 

 

 

 

 

 

123,419

 

Accounts receivables

 

 

 

 

 

6,099

 

 

 

 

 

 

 

 

 

 

 

 

6,099

 

Other current/non-current assets*

 

 

 

 

 

2,388

 

 

 

 

 

 

 

 

 

28,034

 

 

 

30,422

 

Current/non-current liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payables

 

 

 

 

 

 

 

 

 

 

 

18,832

 

 

 

 

 

 

18,832

 

Other current liabilities

 

 

 

 

 

 

 

 

 

 

 

50

 

 

 

5,557

 

 

 

5,607

 

Lease liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

15,635

 

 

 

15,635

 

Total

 

 

 

 

 

477,824

 

 

 

 

 

 

18,882

 

 

 

49,226

 

 

 

 

 

 

Carrying amount per measurement category

 

 

 

 

 

 

 

 

Financial assets as of December 31, 2024

 

 

Financial liabilities as of December 31, 2024

 

 

 

 

 

 

 

(Euros in thousands)

 

At fair value
through profit
and loss

 

 

At amortized
cost

 

 

At fair value
through profit
and loss

 

 

At amortized
cost

 

 

IFRS 7 not
applicable and
IFRS 16

 

 

December 31, 2024

 

Current/non-current assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

 

 

 

236,748

 

 

 

 

 

 

 

 

 

 

 

 

236,748

 

Short-term deposits*

 

 

 

 

 

367,704

 

 

 

 

 

 

 

 

 

 

 

 

367,704

 

Accounts receivables

 

 

 

 

 

5,857

 

 

 

 

 

 

 

 

 

 

 

 

5,857

 

Other current/non-current assets*

 

 

 

 

 

1,244

 

 

 

 

 

 

 

 

 

19,252

 

 

 

20,496

 

Current/non-current liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payables

 

 

 

 

 

 

 

 

 

 

 

20,693

 

 

 

 

 

 

20,693

 

Other current liabilities

 

 

 

 

 

 

 

 

 

 

 

50

 

 

 

6,755

 

 

 

6,805

 

Liabilities for warrants

 

 

 

 

 

 

 

 

1,730

 

 

 

 

 

 

 

 

 

1,730

 

Lease liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

16,203

 

 

 

16,203

 

Total

 

 

 

 

 

611,553

 

 

 

1,730

 

 

 

20,743

 

 

 

42,210

 

 

 

 

 

* “Short-term deposits” are classified within the balance sheet item “other financial assets”. Other current/non-current assets classified as financial instruments comprise mainly of deposits.

The book value of financial assets and liabilities other than lease liabilities and liabilities for warrants represent a reasonable approximation of the fair value.

All financial liabilities classified as "at fair value through profit or loss" are measured by using quoted prices in an active market for identical assets and liabilities (Level 1), respectively.

Liabilities for warrants are comprised of the Immatics Warrants issued to investors with a cashless exercise mechanism as a current liability which the Company accounted for according to provisions of IAS 32. The Company measures the warrants at fair value by using the closing price of warrants at Nasdaq. The warrants are measured in each reporting period. Changes in the fair value are recognized in the Company’s Consolidated Statement of Profit or Loss as financial income or expenses, as appropriate. The warrants are classified as Level 1 of the fair value hierarchy. The maturity of the liabilities for warrants is dependent on the development of the share price as well as the decisions by the Immatics Warrants holders. The warrants expired on July 1, 2025.

The Group’s net results from financial instruments by measurement categories are disclosed below for the years ended December 31, 2025, 2024 and 2023, respectively.

 

 

Year ended December 31,

 

(Euros in thousands)

 

2025

 

 

2024

 

 

2023

 

Financial assets at amortized cost

 

 

(17,544

)

 

 

43,583

 

 

 

7,612

 

Financial liabilities at amortized cost

 

 

(946

)

 

 

(886

)

 

 

(802

)

Financial liabilities at fair value through profit or loss

 

 

1,730

 

 

 

17,264

 

 

 

(2,079

)

Total

 

 

(16,760

)

 

 

59,961

 

 

 

4,731

 

 

The following table shows the changes of the liabilities from financing activities, classified as cash effective and non-cash effective as of December 31, 2025 and 2024, respectively.

 

 

(Euros in thousands)

 

January 1, 2025

 

 

Cash effective

 

 

Non-cash effective

 

 

December 31, 2025

 

Liabilities for warrants

 

 

1,730

 

 

 

 

 

 

(1,730

)

 

 

 

Lease Liabilities

 

 

16,203

 

 

 

(2,959

)

 

 

2,391

 

 

 

15,635

 

Total

 

 

17,933

 

 

 

(2,959

)

 

 

661

 

 

 

15,635

 

 

(Euros in thousands)

 

January 1, 2024

 

 

Cash effective

 

 

Non-cash effective

 

 

December 31, 2024

 

Liabilities for warrants

 

 

18,993

 

 

 

 

 

 

(17,263

)

 

 

1,730

 

Lease Liabilities

 

 

15,402

 

 

 

(2,012

)

 

 

2,813

 

 

 

16,203

 

Total

 

 

34,395

 

 

 

(2,012

)

 

 

(14,450

)

 

 

17,933